Thurnher, Martin <br/><br/>
Novel aspects of mevalonate pathway inhibitors as antitumor agents.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jul 2012 
 - 3524-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-0489  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Diphosphonates--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Immunity, Innate--drug effects<br/>Immunologic Factors--pharmacology<br/>Metabolic Networks and Pathways--drug effects<br/>Mevalonic Acid--metabolism<br/>Neoplasms--drug therapy<br/>Prenylation<br/>Protein Processing, Post-Translational--drug effects